It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

CVS Health (NYSE:CVS) shares extended six straight sessions of losses, as the stock slipped 0.7% at $63.38 on Thursday. The ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...